86 related articles for article (PubMed ID: 12625296)
1. Cholesterol-lowering drug improves survival after heart transplant.
FDA Consum; 2003; 37(1):7-8. PubMed ID: 12625296
[No Abstract] [Full Text] [Related]
2. Safety and efficacy of ezetimibe with low doses of simvastatin in heart transplant recipients.
Quarta CC; Potena L; Grigioni F; Scalone A; Magnani G; Coccolo F; Fallani F; Russo A; Branzi A
J Heart Lung Transplant; 2008 Jun; 27(6):685-8. PubMed ID: 18503971
[TBL] [Abstract][Full Text] [Related]
3. [Simvastatin 40 mg as secondary prophylaxis: Effective, tolerable and cost-efficient!].
Hernborg A; Hjemdahl P; Håkansson J
Lakartidningen; 2006 Mar 15-21; 103(11):858, 861; discussion 861-2. PubMed ID: 16613120
[No Abstract] [Full Text] [Related]
4. [Value of the CSE-inhibitor Pravastatin in the lowering of cholesterol after heart and kidney transplantation].
Dtsch Med Wochenschr; 1997 Jan; 122(3 Suppl):1-7. PubMed ID: 9130880
[No Abstract] [Full Text] [Related]
5. Treatment of high-risk patients with ezetimibe plus simvastatin co-administration versus simvastatin alone to attain National Cholesterol Education Program Adult Treatment Panel III low-density lipoprotein cholesterol goals.
Feldman T; Koren M; Insull W; McKenney J; Schrott H; Lewin A; Shah S; Sidisin M; Cho M; Kush D; Mitchel Y
Am J Cardiol; 2004 Jun; 93(12):1481-6. PubMed ID: 15194017
[TBL] [Abstract][Full Text] [Related]
6. [Even at LDL cholesterol 100mg/dl. "Every coronary disease patient has to receive a statin"].
MMW Fortschr Med; 2003 Dec; 145(49):57. PubMed ID: 14963997
[No Abstract] [Full Text] [Related]
7. Efficacy, safety and LDL-C goal attainment of ezetimibe 10 mg-simvastatin 20 mg vs. placebo-simvastatin 20 mg in UK-based adults with coronary heart disease and hypercholesterolaemia.
Patel JV; Hughes EA
Int J Clin Pract; 2006 Aug; 60(8):914-21. PubMed ID: 16893434
[TBL] [Abstract][Full Text] [Related]
8. Hypercholesterolemia is common after pediatric heart transplantation: initial experience with pravastatin.
Seipelt IM; Crawford SE; Rodgers S; Backer C; Mavroudis C; Seipelt RG; Pahl E
J Heart Lung Transplant; 2004 Mar; 23(3):317-22. PubMed ID: 15019641
[TBL] [Abstract][Full Text] [Related]
9. Twenty-four more days.
Goldstein MR
Am J Cardiol; 1998 Sep; 82(5):703-4. PubMed ID: 9732913
[No Abstract] [Full Text] [Related]
10. [Clinicohemadynamic and biochemical the effect of patients with coronary heart disease use combinated lactoovovegetarian diets and simvastatin].
Medkova IL; Ivanov AN; Mosiakina LI; Biriukova LS
Vopr Pitan; 2006; 75(5):49-52. PubMed ID: 17172171
[TBL] [Abstract][Full Text] [Related]
11. [Heart Protection Study].
Larsen ML; Hildebrandt PR
Ugeskr Laeger; 2002 Jan; 164(3):348. PubMed ID: 11816337
[No Abstract] [Full Text] [Related]
12. Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: the Vytorin Versus Atorvastatin (VYVA) study.
Ballantyne CM; Abate N; Yuan Z; King TR; Palmisano J
Am Heart J; 2005 Mar; 149(3):464-73. PubMed ID: 15864235
[TBL] [Abstract][Full Text] [Related]
13. [Statin treatment in type 2 diabetes. Is it a must today?].
Faust M
MMW Fortschr Med; 2003 Feb; 145(9):35-6. PubMed ID: 12666527
[No Abstract] [Full Text] [Related]
14. Lipid-altering efficacy of switching from atorvastatin 10 mg/day to ezetimibe/simvastatin 10/20 mg/day compared to doubling the dose of atorvastatin in hypercholesterolaemic patients with atherosclerosis or coronary heart disease.
Barrios V; Amabile N; Paganelli F; Chen JW; Allen C; Johnson-Levonas AO; Massaad R; Vandormael K
Int J Clin Pract; 2005 Dec; 59(12):1377-86. PubMed ID: 16351668
[TBL] [Abstract][Full Text] [Related]
15. Effect of co-administering ezetimibe with on-going simvastatin treatment on LDL-C goal attainment in hypercholesterolemic patients with coronary heart disease.
Farnier M; Volpe M; Massaad R; Davies MJ; Allen C
Int J Cardiol; 2005 Jul; 102(2):327-32. PubMed ID: 15982505
[TBL] [Abstract][Full Text] [Related]
16. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis (the SEAS trial).
Farmer JA
Curr Atheroscler Rep; 2009 Mar; 11(2):82-3. PubMed ID: 19228479
[No Abstract] [Full Text] [Related]
17. [Coronary disease prevention: only the inhibition of inflammation is important. Why lower lipids, too?].
Sudhop T; von Bergmann K
MMW Fortschr Med; 2003 May; 145(21):19. PubMed ID: 12845862
[No Abstract] [Full Text] [Related]
18. Effects of celiprolol and simvastatin on the calculated risk of coronary heart disease (the Celisimva study).
Olkinuora JT; Viikari J; Vanhanen H; Makkonen N; Kalliomäki T
Scand Cardiovasc J; 2006 Jun; 40(3):160-6. PubMed ID: 16798663
[TBL] [Abstract][Full Text] [Related]
19. LDL-C goal attainment with ezetimibe plus simvastatin coadministration vs atorvastatin or simvastatin monotherapy in patients at high risk of CHD.
McKenney J; Ballantyne CM; Feldman TA; Brady WE; Shah A; Davies MJ; Palmisano J; Mitchel YB
MedGenMed; 2005 Jul; 7(3):3. PubMed ID: 16369229
[TBL] [Abstract][Full Text] [Related]
20. [Coronary disease after transplantation reduces the survival time of patients].
Persson S; Boman K; Dahlström U
Lakartidningen; 1990 May; 87(18):1562, 1565. PubMed ID: 2335999
[No Abstract] [Full Text] [Related]
[Next] [New Search]
